uce
ProgressImage ProgressImage
Alivus Life Sciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543322 border-img ISIN Demat INE03Q201024 border-img Book Value 229.75 border-img NSE Symbol ALIVUS border-img Div & Yield % 0.45 border-img Market Cap ( Cr.) 13496.56 border-img P/E 27.79 border-img EPS 39.6 border-img Face Value 2
Quarters
ParticularsMar 2025
()
Dec 2024
()
Sep 2024
()
Gross Sales649.55641.84506.88
Other Operating Income0.000.000.00
Other Income 10.0910.468.53
Total Income659.63652.30515.41
Total Expenditure 451.11451.54372.52
PBIDT208.52200.76142.89
Interest 1.260.460.34
PBDT207.26200.31142.55
Depreciation15.9715.1615.09
Tax47.8846.8130.24
Fringe Benefit Tax0.000.000.00
Deferred Tax1.551.381.90
Reported Profit After Tax141.87136.9695.32
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item141.87136.9695.32
    
EPS (Unit Curr.)11.5711.187.78
EPS (Adj) (Unit Curr.)11.5711.187.78
Calculated EPS (Unit Curr.)11.5811.187.78
Calculated EPS (Adj) (Unit Curr.)11.5811.187.78
Calculated EPS (Ann.) (Unit Curr.)46.3144.7131.12
Calculated EPS (Adj) (Ann.) (Unit Curr.)46.3144.7131.12
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity24.5124.5124.51
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)32.1031.2828.19
PBDTM(%)31.9131.2128.12
PATM(%)21.8421.3418.81
x
x
×
Let's Chat
close
refresh